Cargando…
An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies
As the leading cause of cancer death, cervical cancer ranks fourth for both incidence and mortality. Cervical cancer incidence and mortality rates have reportedly decreased over the last decades thanks to extensive screening and widespread vaccination against human papilloma virus. However, there ha...
Autores principales: | Liu, Lei, Wang, Min, Li, Xianping, Yin, Sheng, Wang, Bingqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355560/ https://www.ncbi.nlm.nih.gov/pubmed/34395473 http://dx.doi.org/10.3389/fmed.2021.682366 |
Ejemplares similares
-
IMPA2 blocks cervical cancer cell apoptosis and induces paclitaxel resistance through p53-mediated AIFM2 regulation: IMPA2 blocks cervical cancer cell apoptosis
por: Xie, Kexin, et al.
Publicado: (2023) -
β-Catenin: oncogenic role and therapeutic target in cervical cancer
por: Wang, Bingqi, et al.
Publicado: (2020) -
Variations in the Wnt/β-Catenin Pathway Key Genes as Predictors of Cervical Cancer Susceptibility
por: Wang, Bingqi, et al.
Publicado: (2020) -
Overview of Ongoing Clinical Trials on Radioembolization
por: Fabritius, Matthias P., et al.
Publicado: (2022) -
Reaction dynamics: overview of ongoing and proposed experiments
por: Heinz, U
Publicado: (1990)